Mainga Hamaluba
B and T cell responses to pre-erythrocytic R21/Matrix-M and blood-stage RH5.1/Matrix-M malaria vaccines in endemic settings.Bundi CK
Mu├▒oz O
Kibwana E
Bellamy D
Stockdale L
Barrett JR
McHugh K
Mtaka I
Kalinga W
Kimani D
Nyamako L
Keter K
Ogwang R
Hill AVS
Bejon P
Hamaluba M
Silk SE
Minassian AM
Draper SJ
Olotu AI
Kapulu MC
Ewer KJ
Nielsen CM
Front Immunol, (2026). 17:1743327
Oral rehydration for severe malnutrition in children with moderate and severe dehydration (GASTROSAM): a phase 2, open-label, superiority randomised controlled trial.Maitland K
Sainna H
Connon R
Ouattara SM
Sunyoto T
Chara A
Ogundipe OF
Maguina AS
Hamaluba M
Olupot-Olupot P
Alaroker F
Okiror W
Aromut D
Mwajombo E
Oguda E
Mogaka C
Langendorf C
Dewez JE
Ciglenecki I
Gibb DM
Petrucci R
Coldiron ME
George EC
Lancet Child Adolesc Health, (2026). :
A cost-consequence analysis of the children's administration oxygenation strategies trial (COAST) in severe pneumonia.Carroll OU
Grieve R
Kiguli S
Olupot-Olupot P
Opoka RO
Alaroker F
Tagoola A
Hamaluba M
Nabawanuka E
Nalwanga D
Williams TN
Thomas K
Harrison DA
Mouncey P
Giallongo E
Rowan K
Maitland K
Sadique Z
PLOS Glob Public Health, (2026). 6:e0005654
Determining the dose-response relationship for pneumococcal conjugate vaccines: a nested analysis of the fractional dose PCV trial.Martinez-de-Albeniz I
Bottomley C
Lucinde R
Kaniu MW
Badaud S
Mutahi M
Mwalekwa L
Ragab S
Twi-Yeboah L
Berkley JA
Hamaluba M
Karani A
Shangala J
Otiende M
Gardiner E
Mugo D
Smith PG
Tabu C
Were F
Goldblatt D
Scott JAG
Gallagher KE
Vaccine, (2026). 73:128186
Malaria vaccine protection against intradermal or venous parasites: a randomized phase 2b human challenge trial.Kapulu MC
Orenge F
Kimani D
Kibwana E
Kibet H
Mutahi M
Datoo MS
Bellamy D
Musembi J
Ngoto O
Rashid H
Akinyi S
Mwatasa MH
Nyamako L
Keter K
Gatheru R
Mutiso A
Musyoki J
Mwacharo J
Abebe Y
James ER
Billingsley PF
Ngetsa C
Mosobo M
Makale J
Tawa B
Wamae K
Ochola-Oyier LI
Lawrie A
Ramos-Lopez F
Roberts R
Richie TL
Sim BKL
Hoffman SL
Ewer KJ
Hill AVS
Hamaluba M
Bejon P
Nat Med, (2026). 32:178-185
Pf8: an open dataset of Plasmodium falciparum genome variation in 33,325 worldwide samples.Malaria Genomic Epidemiology Network
Abdel Hamid MM
Abdelraheem MH
Acheampong DO
Adam I
Aide P
Ajibaye O
Ali M
Almagro-Garcia J
Amambua-Ngwa A
Amenga-Etego L
Aniebo I
Aninagyei E
Ansah F
Apinjoh TO
Ariani CV
Auburn S
Awandare GA
Balmer A
Bejon P
Boene S
Bwire G
Candrinho B
Chidimatembue A
Chindavongsa K
Comiche K
Conway D
Dara A
Diakite M
Djimde A
Dondorp A
Doumbia S
Drury E
Fanello CA
Ferdig M
Figueroa K
Gamboa D
Golassa L
Goncalves S
Guindo MDA
Hamaluba M
Hanboonkunupakarn B
Howe K
Hussien M
Imwong M
Ishengoma D
Jeans J
Kabaghe A
Kamuhabwa A
Kindermans JM
Konate DS
Kwiatkowski DP
Lee C
Lee SK
Lee SJ
Ley B
Llanos-Cuentas A
Marfurt J
Matambisso G
Maude RR
Maude RJ
Mayor A
Mayxay M
Maiga-Ascofare O
McCann RS
Miles A
Miotto O
Mohamed AO
Morang'a CM
Murie K
Ngasala BE
Nguyen TN
Nolasco O
Nosten F
Noviyanti R
O'Connor I
Oboh M
Ochola-Oyier LI
Olufunke Falade C
Olukosi A
Olumide A
Olusola FI
Onyamboko MA
Oriero EC
Oyibo WA
Pannebaker D
Pearson RD
Phiri K
van der Pluijm RW
Price RN
Quang HH
Rajkumar Devaraju V
Randrianarivelojosia M
Ranford-Cartwright L
Rayner JC
Rovira-Vallbona E
Rowlands K
Ruano-Rubio V
Sanchez JF
Saute F
Shettima S
da Silva C
Simpson VJ
Suddaby S
Takken W
Thu AM
Toure M
Unlu E
Valdivia HO
van Vugt M
Waithira N
Wellems T
Wendler J
White N
Wuendrich Ogidan R
Wellcome Open Res, (2025). 10:325
A Pragmatic Trial of Glucocorticoids for Community-Acquired Pneumonia.Lucinde RK
Gathuri H
Mwaniki P
Orindi B
Otieno EO
Mwakio S
Mulemi L
Isaaka L
Shangala J
Saisi M
Isinde E
Oginga IN
Wachira AW
Manuthu E
Kariuki H
Asaava P
Nyikuli J
Wekesa C
Otedo A
Bosire H
Okoth SB
Ongalo W
Mukabi DM
Lusamba W
Muthui B
Adembesa I
Mithi C
Sood M
Aliyan NA
Gituma B
Matiko MG
Omondi CA
Ombajo LA
Kirui N
Ochola L
Abdi AI
Kagucia EW
English M
Hamaluba M
Ochola-Oyier I
Kamuya D
Bejon P
Barasa E
Agweyu A
Akech S
Etyang AO
N Engl J Med, (2025). 393:2187-2197
R21/Matrix-M malaria vaccine drives diverse immune responses in pre-exposed adults: insights from a phase IIb controlled human malaria infection trial.Kibwana E
Bundi C
Kimani D
Nyamako L
Keter K
Mutiso A
Ogwang R
Bellamy D
Rapi K
Bajer A
Provstgaard-Morys S
Stockdale L
Munoz O
Datoo MS
Lawrie A
Ramos-Lopez F
Roberts R
Hamaluba M
Hill AVS
Bejon P
Ewer KJ
Kapulu M
Front Immunol, (2025). 16:1620365
Vaccine-induced responses to R21/Matrix-M - an analysis of samples from a phase 1b age de-escalation, dose-escalation trial.Bundi C
Bellamy D
Kibwana E
Nyamako L
Ogwang R
Keter K
Kimani D
Salman AM
Provstgaard-Morys S
Stockdale L
Hill AVS
Bejon P
Olotu A
Hamaluba M
Ewer KJ
Kapulu MC
Front Immunol, (2025). 16:1620366
Early weaning from oxygen therapy in African children with severe pneumonia.Maitland K
Giallongo E
Hamaluba M
Alaroker F
Opoka RO
Tagoola A
Nalwanga D
Nabawanuka E
Okiror W
Nakuya M
Aromut D
Williams TN
Thomas K
Harrison DA
Mouncey P
Bush A
Fraser JF
Rowan K
Olupot-Olupot P
Kiguli S
Coast trial group
BMC Med, (2025). 23:366
Supplementation with ready-to-use therapeutic food has no effect on adverse outcomes among undernourished children aged 6-59ÔÇ»months with severe pneumonia.Nalwanga D
Giallongo E
Musiime V
Kiguli S
Olupot PO
Alaroker F
Opoka R
Tagoola A
Hamaluba M
Mogaka C
Nabawanuka E
Karamagi C
Briend A
Maitland K
Front Nutr, (2025). 12:1507360
A pragmatic randomized controlled trial of standard care versus corticosteroids plus standard care for treatment of pneumonia in adults admitted to Kenyan hospitals (SONIA).Lucinde R
Abdi A
Orindi B
Mwakio S
Gathuri H
Onyango E
Chira S
Ogero M
Isaaka L
Shangala J
Oginga IN
Wachira A
Manuthu E
Kariuki H
Nyikuli J
Wekesa C
Otedo A
Bosire H
Okoth SB
Ongalo W
Mukabi D
Lusamba W
Muthui B
Kirui N
Adembesa I
Mithi C
Sood M
Ahmed N
Gituma B
Ongaki VB
Giabe M
Omondi C
Ombajo LA
Kagucia W
English M
Hamaluba M
Ochola-Oyier LI
Kamuya D
Bejon P
Agweyu A
Akech S
Etyang AO
Wellcome Open Res, (2025). 7:269
Intravenous Rehydration for Severe Acute Malnutrition with Gastroenteritis.Maitland K
Ouattara SM
Sainna H
Chara A
Ogundipe OF
Sunyoto T
Hamaluba M
Olupot-Olupot P
Alaroker F
Connon R
Saidou Maguina A
Okiror W
Amorut D
Mwajombo E
Oguda E
Mogaka C
Langendorf C
Dewez JE
Ciglenecki I
Gibb DM
Coldiron ME
Petrucci R
George EC
Gastrosam Trial Group
N Engl J Med, (2025). 393:1257-1268
COVID-19 mortality in Africa and Asia - Authors' reply.Bejon P
Agweyu A
Oyier I
Hamaluba M
Kamuya D
Kinyanjui S
Barasa E
Lancet Infect Dis, (2025). 25:e440
Rethinking the evidence on COVID-19 in Africa.Bejon P
Agweyu A
Ochola-Oyier LI
Hamaluba M
Kamuya D
Kinyanjui S
Barasa E
Lancet Infect Dis, (2025). 25:e463-e471
Investigating the dynamics of Plasmodium falciparum gametocyte carriage in expectant women under intermittent preventive treatment with sulfadoxine-pyrimethamine in Kilifi, study protocol.Kiyuka PK
Muricho M
Ouma N
Muiruri C
Nyaguara A
Rono M
Oyier I
Hamaluba M
Open Res Eur, (2025). 5:60
Development of an oral regimen of unithiol for the treatment of snakebite envenoming: a phase 1 open-label dose-escalation safety trial and pharmacokinetic analysis in healthy Kenyan adults.Abouyannis M
Nyambura YK
Ngome S
Riako D
Musyoki J
Muiruri C
Orindi B
Else L
Amara A
Dickinson L
Clare RH
Albulescu LO
Westhorpe AP
Kool J
Adetifa I
Ndungu FM
FitzGerald R
Khoo S
Lalloo DG
Casewell NR
Hamaluba M
EBioMedicine, (2025). 113:105600
Fractional Doses of Pneumococcal Conjugate Vaccine - A Noninferiority Trial.Gallagher KE
Lucinde R
Bottomley C
Kaniu M
Suaad B
Mutahi M
Mwalekwa L
Ragab S
Twi-Yeboah L
Berkley JA
Hamaluba M
Karani A
Shangala J
Otiende M
Gardiner E
Mugo D
Smith PG
Tabu C
Were F
Goldblatt D
Scott JAG
N Engl J Med, (2024). 391:2003-2013
Evaluation of hydroxychloroquine or chloroquine for the prevention of COVID-19 (COPCOV): A double-blind, randomised, placebo-controlled trial.Schilling WHK
Mukaka M
Callery JJ
Llewelyn MJ
Cruz CV
Dhorda M
Ngernseng T
Waithira N
Ekkapongpisit M
Watson JA
Chandna A
Nelwan EJ
Hamers RL
Etyang A
Beg MA
Sow S
Yavo W
Allabi AC
Basnyat B
Sharma SK
Amofa-Sekyi M
Yonga P
Adler A
Yuentrakul P
Cope T
Thaipadungpanit J
Rienpradub P
Imwong M
Abdad MY
Blacksell SD
Tarning J
Goudjo FF
Dossou AD
Konate-Toure A
Assi SB
Ouffoue K
Nasronudin N
Rachman BE
Romadhon PZ
Dewanto DD
Heryana MO
Novi T
Pasaribu AP
Mutiara M
Nasution MPR
Khairunnisa K
Dalimunthe FA
Airlangga E
Fahrezzy A
Subronto Y
Ananda NR
Rahardjani M
Rimainar A
Lucinde RK
Timbwa M
Onyango OE
Agutu C
Akech S
Hamaluba M
Kipyego J
Ngachi O
Haidara FC
Traore OY
Diarra F
Khanal B
Dahal P
Shrestha S
Rijal S
Kabore Y
Adehossi E
Guindo O
Qamar FN
Kazi AM
Woodrow CJ
Laird S
Cheeba M
Ayles H
Cheah PY
Taylor WRJ
Batty EM
Chotivanich K
Pukrittayakamee S
Phumratanaprapin W
von Seidlein L
Dondorp A
Day NPJ
White NJ
Copcov Collaborative Group
PLoS Med, (2024). 21:e1004428
SEVUparin as a potential Adjunctive Treatment in children with severe malaria: A phase I trial safety and dose finding trial (SEVUSMAART).Maitland K
Hamaluba M
Obonyo N
Oguda E
Mogoka C
Williams TN
Chaponda M
Miti S
Kamavu LK
Jonathan Gwasupika J
Connon R
Gibb DM
Dondorp A
Day N
White N
Walker AS
George EC
Severe Malaria in African Children AResearch
Trials consortium
Wellcome Open Res, (2024). 8:484
